Vioxx in Colorectal Cancer Therapy: Definition of Optimal Regimen - VICTOR


The goal of the analysis was to evaluate the frequency of cardiovascular thrombotic events with the cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with placebo among patients with colorectal cancer. The trial was designed to evaluate the effect of rofecoxib on reduction in tumor recurrence.